一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>251303-04-5

251303-04-5

中文名稱 ERTIPROTAFIB
英文名稱 Ertiprotafib
CAS 251303-04-5
分子式 C31H27BrO3S
分子量 559.52
MOL 文件 251303-04-5.mol
更新日期 2024/07/24 18:26:22
251303-04-5 結(jié)構(gòu)式 251303-04-5 結(jié)構(gòu)式

基本信息

中文別名
化合物 T15243
英文別名
PTP 112
Ertiprotafib
Benzenepropanoic acid, a-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-,(aR)-
Benzenepropanoic acid, α-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (αR)-
所屬類別
生物化工:抑制劑

物理化學(xué)性質(zhì)

沸點(diǎn)690.7±55.0 °C(Predicted)
密度1.376±0.06 g/cm3(Predicted)
儲存條件-20°C儲存
溶解度溶于二甲基亞砜
酸度系數(shù)(pKa)3.21±0.10(Predicted)
形態(tài)Solid
顏色Light yellow to yellow
化合物 T15243價格(試劑級)
報價日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價格
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-51 mg1590元
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-55 mg3500元
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-510 mM * 1 mLin DMSO4308元

常見問題列表

生物活性
Ertiprotafib 是 PTP1B, IKK-β 的抑制劑,其 IC50 值分別是 1.6 μM,400 nM,同時也是PPARα/PPARβ 的激動劑,其 EC50 值為 ~1 μM。
靶點(diǎn)

PTP1B

1.6 μM (IC 50 )

IKK-β

400 nM (IC 50 )

PPARα

~1 μM (EC 50 )

PPARβ

~1 μM (EC 50 )

體外研究

Ertiprotafib is a potent inhibitor of IKK-β, with an IC 50 value of 400±40 nM, which is much lower than that required for the half-maximal inhibition of the p-nitrophenyl phosphatase activity of PTP1B. The reported IC 50 value of Ertiprotafib against PTP1B ranges from 1.6 to 29 μM depending on the assay conditions. Ertiprotafib is at least a dual PPARα and PPARβ agonist with EC 50 values for transactivation of 1 μM. Such activities readily explain the observations with suprapharmacologic doses of these.

體內(nèi)研究

As seen with treatment of ob/ob mice, both Ertiprotafib and compound 3 seem to significantly improve glucose metabolism in rats. At 25 mg/kg/day, these compounds decrease both fasting blood glucose and insulin levels compared with vehicle treated rats. Furthermore, both Ertiprotafib and compound 3 increase glucose disposal after an oral challenge. It is noteworthy that lipid levels are also reduced in treated animals. Both triglyceride and free fatty acid levels are substantially reduced in rats treated with 25 mg/kg/day of either compound. To summarize, both Ertiprotafib and compound 3 seem to be robust agents in improving glucose utilization in fa/fa rats while also decreasing lipid levels in these animals. Decreased lipid levels may be unexpected for a pure PTP1b inhibitor. It is more telling, as mentioned above, that rats treated with suprapharmacologic doses of Ertiprotafib show signs of PPAR family activation.

"251303-04-5" 相關(guān)產(chǎn)品信息
若尔盖县| 阿拉善盟| 祁门县| 霍林郭勒市| 利川市| 泗水县| 泽库县| 海原县| 石河子市| 清新县| 太仆寺旗| 剑川县| 洛扎县| 九龙坡区| 新密市| 莱州市| 洪雅县| 兴国县| 元朗区| 金湖县| 澄迈县| 霍林郭勒市| 江川县| 松原市| 德州市| 当雄县| 永川市| 绥宁县| 楚雄市| 新田县| 宣化县| 苏尼特左旗| 临猗县| 宁蒗| 锡林浩特市| 连江县| 井冈山市| 亳州市| 长春市| 杭锦后旗| 额敏县|